These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7725039

  • 21. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM.
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [Abstract] [Full Text] [Related]

  • 22. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [Abstract] [Full Text] [Related]

  • 23. [Urinary incontinence: anticholinergic treatment].
    Jimenez Cidre MA.
    Rev Med Univ Navarra; 2004 Jul; 48(4):37-42. PubMed ID: 15810718
    [Abstract] [Full Text] [Related]

  • 24. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K.
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H.
    J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Two-stage transperineal management of posterior urethral strictures or bladder neck contractures associated with urinary incontinence after prostate surgery and endoscopic treatment failures.
    Simonato A, Gregori A, Lissiani A, Carmignani G.
    Eur Urol; 2007 Nov; 52(5):1499-504. PubMed ID: 17418481
    [Abstract] [Full Text] [Related]

  • 33. Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence.
    Cespedes RD, Cross CA, McGuire EJ.
    J Urol; 1996 Nov; 156(5):1744-7. PubMed ID: 8863585
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC.
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacological agents for the treatment of urinary incontinence due to overactive bladder.
    Wein AJ.
    Expert Opin Investig Drugs; 2001 Jan; 10(1):65-83. PubMed ID: 11116281
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.